Eli Lilly Strikes $2.75 Billion AI Drug Discovery Alliance With Insilico Medicine
Eli Lilly partners with Insilico Medicine in a landmark $2.75 billion deal, gaining exclusive access to AI-driven drug discovery tools to accelerate therapeutic development.
|5 min read